Home Food & Beverage global-prebiotics-for-infant-formula-market

Food & Beverage

Image

Global Prebiotics for Infant Formula Market – Industry Trends and Forecast to 2027

  • Food & Beverage
  • Published Report
  • Dec 2019
  • Global
  • 350 Pages
  • No of Tables: 483
  • No of Figures: 55

Global Prebiotics for Infant Formula Market By Ingredient (Carbohydrates, Fats & Oils, Proteins, Vitamins, Minerals, Prebiotics, Others), Form (Powder, Liquid and Semi-Liquid), Source (Cow milk, Soy, Protein Hydrolysates), Distribution Channel (Hypermarkets/Supermarkets, Pharmacies and Drug Stores, Specialty Stores, Online Sales), Application (Functional Food & Beverages, Dietary Supplements, Feed), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis and Insights: Global Prebiotics for Infant Formula Market

Prebiotics for infant formula market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with the CAGR of 6.7% in the forecast period of 2020 to 2027and expected to reach USD 1,761.92 million by 2027. Increasing demand of the infant formulas sue to rising infant population is driving factor for the market growth.

Prebiotics are the rich source of nutrition which is given to infants for their healthy growth. The various prebiotics like human milk oligosaccharides, galactooligosaccharides (GOS), fructooligosaccharides (FOS), mannan-oligosaccharides (MOS) and others improves the digestive system as well as immune system in the infants. Heathy immune system helps infants to increase their physical strengths as well as memory growth. It acts as a substitute for the mother milk as even mother milk is failing to meet the nutritional requirements which increased importance of prebiotics in global market.

Growing number of prebiotics based infant formula products as compared to the past few years will accelerate the market growth. Rise in the number of preterm babies is accelerating the consumption of prebiotics for infant formula products which drives the market. For instance, in 2018, U.S. witnessed rise in the count of premature babies such as it reached to 9.9 percent for year 2017 from the 9.6 in year 2015. Increasing number of preterm babies in a developed nation like U.S. is augmenting the additional nutritional demand for infant which drives the market growth.

This prebiotics for infant formula market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Prebiotics for Infant Formula Market

Global Prebiotics for Infant Formula Market Scope and Market Size

Prebiotics for infant formula market is segmented on the basis of type, source, grade, form, product type and infant age. The growth among segments helps you to analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of type, the market is segmented into human milk oligosaccharides (HMOS), galactooligosaccharides (GOS), fructooligosaccharides (FOS), mannan-oligosaccharides (MOS), polydextrose (PDX), lactulose (LOS), and inulin. The HMOs prebiotics in infant formula plays a major role in the health development of the preterm or premature babies by providing additional nutrition as well as immense care as compared to healthy born babies. The rising number of preterm babies in developing nations is creating huge demand for nutritional product. For intances, In the year 2014, Asia and sub-Saharan Africa region almost had 81 percent of preterm count as compared with the overall world count. With this, these developing regions are creating major demand for the HMO products which ultimately attracts the manufacturers to expand their offering and geographic coverage for those regions.

On the basis of source, the market is segmented into bacteria, algae, fungi, plants & vegetables and others. Plants & vegetables are dominating the market as it offers taste advantages over other sources namely algae, fungi, bacteria and others. The inulin, fructooligosaccharides and other type of prebiotics are sourced from the plants and are used as an alternative sweetener in adult food. Similarly it is used for infant formulas to offer sweetness in end products. In addition, the producers and end product manufactures are using plant and vegetables based prebiotics formula to get a marketing advantage by labelling it as vegetarian product. The acceptance of plant and vegetables based prebiotics in infant formula is high due to the rising trend of organic products which is helping this segment to dominate in the market.

On the basis of grade, the market is segmented into inorganic and organic. Inorganic prebiotics for infant formula is dominating the market due to the prebiotics itself is considered to be costly or non-affordable products for low income or mid-level income customer base due to which extra price of organic products will result in dominance of inorganic prebiotics for infant formula in the market. The organic based prebiotics product has started getting attention from the customer from the past few years due to rising concern over the chemicals content in food products and changing lifestyle.

On the basis of form, the market is segmented into powder and liquid. Powder is dominating the market as the production cost of powder form derived prebiotics is comparatively very less over liquid form which gives a competitive advantage for this segment in the market. The manufacturers are trying to offer liquid form prebiotics for formulas due to its easy concentration but increasing price of final products makes it less demandable over powder form.

On the basis product type, the market is segmented into standard formula, special formula, follow up formula and toddler formula. The standard formula dominating the market as the standard formulations are required by the infants at age of 0-12 months due to the requirement of high nutritional composition to fulfil the demand of mother’s milk owing to growth of standard formula preferences. The follow up and special formulas are required after 7 months or 12 months of age due to which the standards formula has major importance for infants having age of 0-12 months.

On the basis of infant age, the market is segmented into 0-6 months, 6-12 months and 1-3 years. The 6-12 months segment is dominating the global prebiotics for infant formula market due to growing concern amongst the parents about the knowledge regarding infant food after six months of age is also helping the manufacturers to market the product. The regulatory divisions like WHO, FDA and others strongly prefer breast feeding for 0-6 months of age group children and additional nutritional food for the age group of 6-12 months infants.

 Prebiotics for infant formula Market Country Level Analysis

Prebiotics for infant formula market is analysed and market size information is provided by country, by type, source, grade, form, product type and infant age as referenced above.

The countries covered in the prebiotics for infant formula market report are U.S., Canada and Mexico in North America, Germany, U.K., France, Switzerland, Italy, Spain, Belgium, Netherlands, Poland, Ireland, Austria, Russia, Hungary, Turkey, Lithuania, Norway and Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam and Rest of Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E, Kuwait, South Africa, Rest of Middle East and Africa as a part of Middle East and Africa, Brazil, Argentina, Peru and Rest of South America as part of South America.

Country Level Analysis, By Product Type

Global Prebiotics for Infant Formula Market

North America dominates the prebiotics for infant formula market as the U.S. is leader in prebiotics for infant formula manufacturing and major leaders are generating revenue from U.S. due to high investment and awareness towards the consumption of prebiotics among infants in the U.S. For instance, In in August, 2018, COSUCRA expanded their business by forming new production plant to meet the emerging demand from North America market. The new facility is formed to increase the production with investment of USD 38.50 million. The new production facility has automation solution to increase the production as well as storage capacity. Through this the company enhanced their offering for the countries like such as the U.S. and Canada as there is a huge demand for the products. The Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2020 to 2027 because of increasing business expansion and awareness among the customers. The Japan is leading the growth of Asia-Pacific market due to major adoption of prebiotics in infant formula as well as major sale of ready to drink formulas. While the Germany is dominating the Europe market as the rising infant population with increase number of preterm babies is driving the growth for prebiotics in Europe market.   

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

High Demand of Prebiotics for Infant Formula in Developed Nation

Prebiotics for infant formula market also provides you with detailed market analysis for every country growth in prebiotics for infant formula industry with prebiotics for infant formula sales, components sales, impact of technological development in prebiotics for infant formula and changes in regulatory scenarios with their support for the prebiotics for infant formula market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Prebiotics for Infant Formula Market Share Analysis

Prebiotics for infant formula market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global prebiotics for infant formula market.

The major players covered in the report are Jennewein Biotechnologie GmbH, zuChem Inc., Biosynth Carbosynth, ELICITYL SA, Dextra Laboratories Limited, Glycom A/S, Tereos, Ingredion Incorporated, Royal FrieslandCampina N.V., Südzucker AG, Cargill, Incorporated., Fonterra Co-operative Group, Royal Cosun, COSUCRA, New Francisco (Yunfu City) Biotechnology Corporation Limited, Dana Dairy Group, Glycosyn LLC, DUPONT and other domestic and global players. Prebiotics for infant formula market share data is available for Global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product developments are also initiated by the companies worldwide which are also accelerating the global prebiotics for infant formula market.

For instance,

  • In October 2019, Royal FrieslandCampina N.V. formed partnership with United Dairymen of Arizona (UDA) for early life nutrition product development. Company is increasing their production capacity to produce nutritional products for early nutritional market. Through this company increased their production capacity which increased their product availability for the customers.
  • In August 2019, NZMP, a nutrition brand of the Fonterra Co-operative Group formed partnership with Foodspring, a fitness food provider. The partnership is helped company to develop new nutritional product for customers as well as make it available through by using Foodspring resources. Through this company strengthened product portfolio with increased customer base.

Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for prebiotics for infant formula through expanded model range.

SKU-

TABLE 1 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 3 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 4 GLOBAL FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 5 GLOBAL FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 6 GLOBAL FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 7 GLOBAL GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 8 GLOBAL GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 9 GLOBAL INULIN IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 10 GLOBAL POLYDEXTROSE (PDX) IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 11 GLOBAL MANNAN-OLIGOSACCHARIDES (MOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 GLOBAL LACTULOSE (LOS) IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 13 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 14 GLOBAL PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 15 GLOBAL PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 16 GLOBAL BACTERIA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 17 GLOBAL FUNGI IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 18 GLOBAL ALGAE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 19 GLOBAL OTHERS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 20 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 21 GLOBAL INORGANIC IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 22 GLOBAL ORGANIC IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 23 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 24 GLOBAL POWDER IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 25 GLOBAL LIQUID IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 26 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 27 GLOBAL STANDARD FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 28 GLOBAL SPECIAL FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 29 GLOBAL FOLLOW UP FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 30 GLOBAL TODDLER FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 31 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 32 GLOBAL 6-12 MONTHS IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 33 GLOBAL 0-6 MONTHS IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 34 GLOBAL 1-3 YEARS IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 35 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY COUNTRY,  2018-2027 (USD MILLION)

TABLE 36 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 37 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 38 NORTH AMERICA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 39 NORTH AMERICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 40 NORTH AMERICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 41 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 42 NORTH AMERICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 43 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 44 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 45 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 46 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 47 U.S. PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 48 U.S. HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 49 U.S. FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 U.S. GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 51 U.S. FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 52 U.S. PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 53 U.S. PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 54 U.S. PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 55 U.S. PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 56 U.S. PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 57 U.S. PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 58 CANADA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 59 CANADA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 60 CANADA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 61 CANADA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 62 CANADA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 63 CANADA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 64 CANADA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 65 CANADA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 66 CANADA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 67 CANADA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 68 CANADA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 69 MEXICO PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 70 MEXICO HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 71 MEXICO FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 72 MEXICO GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 73 MEXICO FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 74 MEXICO PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 75 MEXICO PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 76 MEXICO PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 77 MEXICO PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 78 MEXICO PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 79 MEXICO PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 80 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY COUNTRY,  2018-2027 (USD MILLION)

TABLE 81 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 82 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 83 ASIA-PACIFIC FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 84 ASIA-PACIFIC GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 85 ASIA-PACIFIC FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 86 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 87 ASIA-PACIFIC PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 88 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 89 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 90 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET,  BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 91 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 92 JAPAN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 93 JAPAN HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 94 JAPAN FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 95 JAPAN GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 96 JAPAN FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 97 JAPAN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 98 JAPAN PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 99 JAPAN PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 100 JAPAN PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 101 JAPAN PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 102 JAPAN PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 103 CHINA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 104 CHINA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 105 CHINA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 106 CHINA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 107 CHINA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 108 CHINA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 109 CHINA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 110 CHINA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 111 CHINA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 112 CHINA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 113 CHINA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 114 SOUTH KOREA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 115 SOUTH KOREA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 116 SOUTH KOREA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 117 SOUTH KOREA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 118 SOUTH KOREA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 119 SOUTH KOREA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 120 SOUTH KOREA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 121 SOUTH KOREA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 122 SOUTH KOREA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 123 SOUTH KOREA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 124 SOUTH KOREA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 125 INDIA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 126 INDIA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 127 INDIA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 128 INDIA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 129 INDIA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 130 INDIA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 131 INDIA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 132 INDIA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 133 INDIA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 134 INDIA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 135 INDIA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 136 AUSTRALIA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 137 AUSTRALIA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 138 AUSTRALIA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 139 AUSTRALIA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 140 AUSTRALIA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 141 AUSTRALIA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 142 AUSTRALIA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 143 AUSTRALIA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 144 AUSTRALIA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 145 AUSTRALIA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 146 AUSTRALIA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 147 SINGAPORE PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 148 SINGAPORE HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 149 SINGAPORE FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 150 SINGAPORE GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 151 SINGAPORE FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 152 SINGAPORE PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 153 SINGAPORE PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 154 SINGAPORE PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 155 SINGAPORE PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 156 SINGAPORE PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 157 SINGAPORE PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 158 MALAYSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 159 MALAYSIA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 160 MALAYSIA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 161 MALAYSIA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 162 MALAYSIA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 163 MALAYSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 164 MALAYSIA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 165 MALAYSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 166 MALAYSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 167 MALAYSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 168 MALAYSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 169 THAILAND PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 170 THAILAND HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 171 THAILAND FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 172 THAILAND GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 173 THAILAND FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 174 THAILAND PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 175 THAILAND PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 176 THAILAND PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 177 THAILAND PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 178 THAILAND PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 179 THAILAND PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 180 INDONESIA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 181 INDONESIA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 182 INDONESIA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 183 INDONESIA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 184 INDONESIA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 185 INDONESIA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 186 INDONESIA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 187 INDONESIA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 188 INDONESIA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 189 INDONESIA PREBIOTICS FOR INFANT FORMULA MARKET,  BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 190 INDONESIA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 191 PHILIPPINES PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 192 PHILIPPINES HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 193 PHILIPPINES FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 194 PHILIPPINES GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 195 PHILIPPINES FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 196 PHILIPPINES PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 197 PHILIPPINES PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 198 PHILIPPINES PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 199 PHILIPPINES PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 200 PHILIPPINES PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 201 PHILIPPINES PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 202 NEW ZEALAND PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 203 NEW ZEALAND HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 204 NEW ZEALAND FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 205 NEW ZEALAND GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 206 NEW ZEALAND FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 207 NEW ZEALAND PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 208 NEW ZEALAND PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 209 NEW ZEALAND PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 210 NEW ZEALAND PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 211 NEW ZEALAND PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 212 NEW ZEALAND PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 213 VIETNAM PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 214 VIETNAM HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 215 VIETNAM FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 216 VIETNAM GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 217 VIETNAM FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 218 VIETNAM PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 219 VIETNAM PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 220 VIETNAM PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 221 VIETNAM PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 222 VIETNAM PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 223 VIETNAM PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 224 REST OF ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 225 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY COUNTRY,  2018-2027 (USD MILLION)

TABLE 226 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 227 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 228 EUROPE FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 229 EUROPE GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 230 EUROPE FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 231 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027  (USD MILLION)

TABLE 232 EUROPE PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 233 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 234 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 235 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 236 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 237 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 238 GERMANY HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 239 GERMANY FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 240 GERMANY GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 241 GERMANY FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 242 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 243 GERMANY PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 244 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 245 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 246 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 247 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 248 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 249 U.K. HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 250 U.K. FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 251 U.K. GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 252 U.K. FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 253 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 254 U.K. PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 255 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 256 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 257 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 258 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 259 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 260 FRANCE HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 261 FRANCE FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 262 FRANCE GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 263 FRANCE FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 264 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 265 FRANCE PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 266 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 267 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 268 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 269 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 270 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 271 ITALY HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 272 ITALY FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 273 ITALY GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 274 ITALY FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 275 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 276 ITALY PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 277 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 278 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 279 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 280 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 281 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 282 SPAIN HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 283 SPAIN FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 284 SPAIN GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 285 SPAIN FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 286 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 287 SPAIN PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 288 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 289 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 290 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 291 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 292 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 293 DENMARK HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 294 DENMARK FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 295 DENMARK GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 296 DENMARK FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 297 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 298 DENMARK PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 299 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 300 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 301 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 302 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 303 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 304 NETHERLANDS HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 305 NETHERLANDS FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 306 NETHERLANDS GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 307 NETHERLANDS FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 308 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 309 NETHERLANDS PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 310 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 311 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 312 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 313 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 314 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 315 SWITZERLAND HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 316 SWITZERLAND FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 317 SWITZERLAND GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 318 SWITZERLAND FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 319 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 320 SWITZERLAND PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 321 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 322 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 323 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 324 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 325 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 326 POLAND HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 327 POLAND FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 328 POLAND GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 329 POLAND FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 330 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 331 POLAND PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 332 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 333 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 334 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 335 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 336 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 337 RUSSIA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 338 RUSSIA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 339 RUSSIA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 340 RUSSIA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 341 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 342 RUSSIA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 343 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 344 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 345 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 346 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 347 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 348 SWEDEN HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 349 SWEDEN FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 350 SWEDEN GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 351 SWEDEN FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 352 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 353 SWEDEN PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 354 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 355 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 356 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 357 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 358 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 359 BELGIUM HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 360 BELGIUM FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 361 BELGIUM GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 362 BELGIUM FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 363 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 364 BELGIUM PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 365 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 366 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 367 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 368 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 369 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 370 TURKEY HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 371 TURKEY FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 372 TURKEY GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 373 TURKEY FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 374 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 375 TURKEY PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 376 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 377 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 378 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 379 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 380 REST OF EUROPE PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 381 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY COUNTRY,  2018-2027 (USD MILLION)

TABLE 382 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 383 SOUTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 384 SOUTH AMERICA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 385 SOUTH AMERICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 386 SOUTH AMERICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 387 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 388 SOUTH AMERICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 389 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 390 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 391 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 392 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 393 BRAZIL PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 394 BRAZIL HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 395 BRAZIL FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 396 BRAZIL GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 397 BRAZIL FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 398 BRAZIL PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 399 BRAZIL PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 400 BRAZIL PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 401 BRAZIL PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 402 BRAZIL PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 403 BRAZIL PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 404 ARGENTINA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 405 ARGENTINA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 406 ARGENTINA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 407 ARGENTINA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 408 ARGENTINA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 409 ARGENTINA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 410 ARGENTINA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 411 ARGENTINA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 412 ARGENTINA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 413 ARGENTINA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 414 ARGENTINA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 415 REST OF SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 416 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 417 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 418 MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 419 MIDDLE EAST & AFRICA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 420 MIDDLE EAST & AFRICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 421 MIDDLE EAST & AFRICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 422 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 423 MIDDLE EAST & AFRICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 424 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY GRADE, 2018-2027 (USD MILLION)

TABLE 425 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY FORM, 2018-2027 (USD MILLION)

TABLE 426 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 427 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 428 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 429 SOUTH AFRICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 430 SOUTH AFRICA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 431 SOUTH AFRICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 432 SOUTH AFRICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 433 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 434 SOUTH AFRICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 435 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 436 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 437 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 438 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 439 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 440 U.A.E. HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 441 U.A.E. FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 442 U.A.E. GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 443 U.A.E. FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 444 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 445 U.A.E. PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 446 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 447 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 448 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 449 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 450 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 451 SAUDI ARABIA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 452 SAUDI ARABIA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 453 SAUDI ARABIA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 454 SAUDI ARABIA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 455 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 456 SAUDI ARABIA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 457 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 458 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 459 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 460 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 461 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 462 OMAN HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 463 OMAN FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 464 OMAN GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 465 OMAN FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 466 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 467 OMAN PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 468 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 469 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 470 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 471 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 472 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 473 KUWAIT HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 474 KUWAIT FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 475 KUWAIT GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 476 KUWAIT FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 477 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 478 KUWAIT PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 479 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 480 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 481 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 482 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 483 REST OF MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

BROWSE RELATED REPORTS

Asia-Pacific Prebiotics for Infant Formula Market – Industry Trends and Forecast to 2027
Europe Prebiotics for Infant Formula Market – Industry Trends and Forecast to 2027
North America Prebiotics for Infant Formula Market – Industry Trends and Forecast to 2030
Middle East and Africa Prebiotics for Infant Formula Market – Industry Trends and Forecast to 2027

BROWSE RELATED Blogs

Global Prebiotics for Infant Formula Market is Expected to Grow USD 1,761.92 Million by 2027

BROWSE RELATED Press Release

Royal FrieslandCampina N.V., Cargill Incorporated. Ingredion Incorporated are dominating the market for Global Prebiotics for Infant Formula Market in 2019
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Can be used by entire organization across the globe + Downloadable and Printable PDF + 30 + Countries

Buy Now
Request for TOC Speak to Analyst Inquire Before Buying Free Sample Report
Advance Formative Research Customization Request for bulk Reports

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials

David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Image
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Image
Business Intelligence and Analytics,
Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst,
Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director,
Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO,
A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director,
Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager,
Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations,
GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst,
Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager,
Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment
MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer
Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro
Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future